(Q41428882)

30 September 2017

1 reference

title

Current aspects of Lyme disease and other Borrelia burgdorferi infections (English)

1 reference

30 September 2017

0 references

0 references

Berger BW

1

1 reference

30 September 2017

1 April 1997

1 reference

30 September 2017

1 reference

30 September 2017

15

1 reference

30 September 2017

2

1 reference

30 September 2017

247-255

1 reference

Epizootiology of Lyme disease-causing borreliae

30 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Acrodermatitis chronica atrophicans

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Early and late cutaneous manifestations in Ixodes-borne borreliosis (erythema migrans borreliosis, Lyme borreliosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Human granulocytic ehrlichiosis in the upper Midwest United States. A new species emerging?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Association between different clinical manifestations of Lyme disease and different species of Borrelia burgdorferi sensu lato

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Spirochetes Isolated from the Blood of Two Patients with Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Erythema chronicum migrans of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Treatment of erythema chronicum migrans of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

1 reference

7 January 2021

Clinical and microbiologic findings in six patients with erythema migrans of Lyme disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Cultivation of Borrelia burgdorferi from erythema migrans lesions and perilesional skin

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Cultivation of Borrelia burgdorferi from the blood of two patients with erythema migrans lesions lacking extracutaneous signs and symptoms of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Failure of Borrelia burgdorferi to survive in the skin of patients with antibiotic-treated Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Cultivation of Borrelia burgdorferi from human tick bite sites: a guide to the risk of infection

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Lyme disease-a tick-borne spirochetosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Development of Borrelia burgdorferi in ixodid tick vectors

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Detection of Borrelia burgdorferi-specific antigen in antibody-negative cerebrospinal fluid in neurologic Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Borrelia burgdorferi DNA is undetectable by polymerase chain reaction in skin lesions of morphea, scleroderma, or lichen sclerosus et atrophicus of patients from North America

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Immunoblot interpretation criteria for serodiagnosis of early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Absence of Borrelia burgdorferi in patients with localized scleroderma (morphea)

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Environmental risk and prevention of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Bloodstream invasion in early Lyme disease: results from a prospective, controlled, blinded study using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

1 reference

7 January 2021

PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Ocular manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Azithromycin compared with amoxicillin in the treatment of erythema migrans. A double-blind, randomized, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Evaluation of the detection ofBorrelia burgdorferi DNA in urine samples by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Amplification of Borrelia burgdorferi DNA in skin biopsies from patients with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Failure to isolate Borrelia burgdorferi after antimicrobial therapy in culture-documented Lyme borreliosis associated with erythema migrans: report of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Isolation of Borrelia burgdorferi from the blood of seven patients with Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Erythema migrans and early Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Detection of Borrelia burgdorferi DNA by Polymerase Chain Reaction in Synovial Fluid from Patients with Lyme Arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Early disseminated Lyme disease: Lyme meningitis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Survival of Borrelia burgdorferi in antibiotically treated patients with Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Lyme disease: recommendations for diagnosis and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

A specific and sensitive assay for the Lyme disease spirochete Borrelia burgdorferi using the polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Further evidence for Borrelia burgdorferi infection in morphea and lichen sclerosus et atrophicus confirmed by DNA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Cultivation of Borrelia burgdorferi from joint fluid three months after treatment of facial palsy due to Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Induction of an outer surface protein on Borrelia burgdorferi during tick feeding

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Early disseminated Lyme disease: cardiac manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Tick-borne diseases in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Isolation of Borrelia burgdorferi from the myocardium of a patient with longstanding cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

1 reference

7 January 2021

Musculoskeletal manifestations of Lyme disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

The Spirochetal Etiology of Lyme Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

Therapeutic aspects of Lyme borreliosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8635%2805%2970433-2

7 January 2021

10.1016/S0733-8635(05)70433-2

Identifiers

DOI

1 reference

30 September 2017

1 reference

PubMed ID

9098634